ATS 2022: Approach to Lung Nodules in 2022

Shaheen Islam

Post COVID-19 Lung Complications

3rd Advanced Lung Disease: Novel Therapies and Controversies Conference

M. Padilla

Approaching Sarcoidosis Therapy From a 21st Century Perspective

CHEST 2022 Coverage

D. Culver

A Radiologist's Approach to Subsolid Pulmonary Nodules

CHEST 2022 Coverage

A. Guttentag

Rapid Fire Journal Club 6 – SARCORT Trial (ERJ, 2023)

PulmPEEPs

D. Furfaro, L. Hedrick

Advances and Updates in Sarcoidosis: Diagnosis and Treatment of Pulm…

UCLA Health

J. Belperio

Sarcoidosis: Diagnosis and Management

University of Colorado Department of Medicine

N. Held

Interstitial Lung Disease in Rheumatic Diseases

University of Colorado Department of Medicine

M. Griffith

Bronchoscopic Imaging for Interstitial Lung Disease

CHEST 2022 Coverage

G. Zhi Cheng

Management and Treatment Decisions in Progressive Pulmonary Fibrosis

CHEST 2022 Coverage

T. Kulkarni

Year in Review: EULAR 2023 Recommendations on Systemic Sclerosis

Cristiana Sieiro Santos

Rituximab versus Cyclophosphamide for the Treatment of Connective Ti…

Toby Maher

Interstitial Lung Disease in RA: RA-ILD Subtypes, Mortality Risk, RA…

RheumNow

J. Sparks, J. Cush

Review of Interstitial Lung Disease Induced by Anti-ERBB2 Antibody-D…

Paolo Tarantino

Management of Pulmonary Fibrosis in Clinical Practice

National Jewish Health

J. Solomon

Interstitial Lung Disease: Multidisciplinary Discussion

UCLA Health

S. Sam Weigt, E. R. Volkmann, F. Abtin, M. Fishbein

EADV 2024 Insights: Eosinophilic Fasciitis

EADV 2024 Insights

F. Rongioletti

Current and Evolving Paradigm of Anti-Inflammatory Therapy in Pulmon…

Temple Lung Center

R. Gupta

Identifying the Signs and Symptoms of Progressive Pulmonary Fibrosis

The France Foundation

V. Khangoora

Medical Marijuana in Rheumatology: Fact or Fiction?

Keck School of Medicine of USC

A. Wells